Prognostic value of a newly identified malat1 alternatively spliced transcript in breast cancer

HIGHLIGHTS

• who: Didier Meseure from the Department of Genetics, Unit of Pharmacogenetics, Institut Curie, rue d'Ulm, Paris , France have published the Article: Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer, in the Journal: (JOURNAL)
• what: The authors focused on the lncRNA MALAT1 that has been shown dysregulated in various cancer types (Zhang et al, 2015), but poorly studied in breast cancer.
• how: The Cox-proportional hazards regression model was used to assess prognostic significance and the results are presented as hazard ratios and 95% confidence intervals. 1397 Prognostic . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.